Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
about
Cardiac toxicity of trastuzumab in elderly patients with breast cancerEvaluation and management of patients with heart disease and cancer: cardio-oncologyChemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionCancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumabAn update on cardio-oncology.Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.Distinct Aspects of Left Ventricular Mechanical Function Are Differentially Associated With Cardiovascular Outcomes and All-Cause Mortality in the Community.Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography.A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyCardiotoxicity due to chemotherapy: role of cardiac imaging.Cardio-oncology: an ongoing evolution.Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.Cardiotoxicity from the cardiologist's perspective.The use of myocardial strain and newer echocardiography imaging techniques in cancer patients.Should the 'echo guidelines' be followed in cancer patients?Myocardial strain to detect subtle left ventricular systolic dysfunction.Biomarkers for monitoring chemotherapy-induced cardiotoxicity.123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy.Assessment of left ventricular functions with tissue Doppler, strain, and strain rate echocardiography in patients with familial Mediterranean fever.Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study.Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients.Subclinical Myocardial Impairment Occurred in Septal and Anterior LV Wall Segments After Anthracycline-Embedded Chemotherapy and did not Worsen During Adjuvant Trastuzumab Treatment in Breast Cancer Patients.High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.Predicting Cardiotoxic Effects of Carbon Monoxide Poisoning Using Speckle Tracking Echocardiography.Publishing in a heart failure journal-where lies the scientific interest?Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study
P2860
Q26741182-0DE93030-6D2E-497B-B267-DDB93205C123Q26998273-4DC643A0-AC35-4558-B34D-64B86400AEE8Q30399577-8E7FE828-0BE5-478D-8617-6C178A114B6DQ34474264-28A67ADB-E864-41F6-ABE5-8C6ECE632EACQ34650059-C0D418E2-6A3C-4ECF-8C98-1485160E102CQ35588736-C1E78644-D970-4249-9774-BA2A80B90E73Q36835998-DD2481BE-FA34-4BD1-900F-531E14CC50ABQ36872695-65C0B4F0-0A53-447E-A3C2-9F4958278900Q37052852-71959FA1-8920-48F4-8198-6E78BE6955E0Q38343043-82EDF137-D793-44E4-AA60-438B75576F7FQ38551766-7BA89A49-FF5D-4A1A-8601-D904D5C4758AQ38773470-A53B4A72-7869-4A65-AAF2-957D67D560AAQ38909573-C57950C6-DC07-4FF8-889C-8C42BC2DD137Q38931763-5CEA44F7-2310-4B7A-A3BC-3B9190116A94Q38978582-267F4E2B-3743-4DBE-BF07-3B49E62FE00DQ38982290-6D94A904-6E29-4294-A349-76BF622F4A71Q38982304-8DA30574-0A71-4ABA-A466-65B59C6B9841Q39021835-8FECD629-24AD-42C2-9451-02581EA88D5CQ39053477-87DD4C83-1EA7-4D91-B967-E20433917F03Q39157770-38569E93-8092-4EC0-815F-9C8D9C9FE476Q42318483-6BDFC62A-AF1F-4E9A-B749-9A133D761385Q47255570-2B12EB12-F014-4930-BC60-CFA6700C11BFQ47643095-1B83E1CA-70F2-4A80-A72B-D81C96ECF09CQ48181773-263926EA-6380-46DB-B5ED-AF3E6D086F3FQ48197501-03E22FB3-88C0-492B-9EC8-1520AECF8F03Q48229649-6767A5CF-067C-4CA5-B8B3-361EFC07EFFBQ50048824-6D260D76-9E92-4893-BA74-6361A85B1A39Q55029106-3FCCA99E-0251-4688-B43E-DC40F8741763Q57260288-ADB0E9B7-1CA4-4009-A2F8-26715E790E01
P2860
Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@en
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@nl
type
label
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@en
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@nl
prefLabel
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@en
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@nl
P2093
P2860
P356
P1476
Two-dimensional speckle tracki ...... pirubicine-based chemotherapy.
@en
P2093
Cuizhen Pan
Haiyan Chen
Leilei Cheng
Minmin Sun
Xianhong Shu
Xiaoping Xu
P2860
P304
P356
10.1002/EJHF.8
P577
2013-12-30T00:00:00Z